Should HIV Patients with Opportunistic Infections Receive Immediate ART?
In a randomized trial, the incidence of AIDS progression or death by 48 weeks was significantly lower among patients who received antiretroviral therapy soon after their OI treatment had started than among those for whom ART was delayed.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)